Article
NCAPH Drives Breast Cancer Progression and Identifies a Gene Signature that Predicts Luminal A Tumor Recurrence
2023-10-16
Abstract excerpt
<title>Abstract</title> <p> Despite their generally favorable prognosis, luminal A tumors paradoxically pose the highest ten-year recurrence risk among breast cancers. From those that relapse, a quarter of them do it within five years after diagnosis. Identifying such patients is crucial, as long-term relapsers could benefit from extended hormone therapy, whereas early relapsers may require aggressive treatment....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e1e24ffa-2c05-56d1-827c-af18577c6f1d
- DOI
- 10.21203/rs.3.rs-3231230/v2
